Latest News about NTLA
Recent news which mentions NTLA
Intellia Therapeutics Earnings Perspective: Return On Capital Employed
February 28, 2023
Tickers
NTLA
From Benzinga
Earnings Scheduled For February 23, 2023
February 23, 2023
From Benzinga
Better Buy: Beam Therapeutics or Intellia Therapeutics?
February 22, 2023
From Motley Fool
3 Deeply Undervalued Stocks That Could Double Your Money
February 15, 2023
From Motley Fool
3 Cathie Wood Stocks That Could More Than Double in 12 Months, According to Wall Street
February 07, 2023
From Motley Fool
3 Cathie Wood Stocks Wall Street Thinks Can Soar 60% to 129%
February 06, 2023
From Motley Fool
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
February 01, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
February 01, 2023
From Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
January 30, 2023
From InvestorPlace
3 Gene Editing Stocks to Buy Now OR You’ll Be Kicking Yourself Later
January 25, 2023
From InvestorPlace
3 Gene Editing Stocks With the Best Long-Term Potential
January 25, 2023
From InvestorPlace
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
January 24, 2023
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 24, 2023
January 24, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Friday
January 20, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
January 19, 2023
From Benzinga
2 Risky Cathie Wood Stocks to Buy Today And Hold For 5 Years
January 07, 2023
From Motley Fool
From Motley Fool
7 ‘Next Big Things’ for Investors to Buy for 2023
December 13, 2022
From InvestorPlace
Ulta Beauty To Rally Around 22%? Here Are 10 Other Price Target Changes For Friday
December 02, 2022
From Benzinga
NTLA Stock Falls as Intellia Therapeutics Announces Public Offering
December 01, 2022
From InvestorPlace
Intellia Therapeutics To Rally Around 143%? Plus Stifel Cuts PT On This Stock By 94%
November 15, 2022
From Benzinga
Intellia's Hereditary Angioedema Candidate Shows Reduction In Associated Biomarkers, Attack Rates
November 14, 2022
Tickers
NTLA
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 1, 2022
November 01, 2022
From Benzinga
3 Cathie Wood Stocks to Buy and Hold for 10 Years
October 19, 2022
From Motley Fool